SEC Tracker
Get the app

Sintx Technologies SINT

Sintx Technologies Q2 FY26: revenue $452K, up 199%; diluted EPS −$0.75

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Sintx Technologies reported for Q2 FY26, the quarter ended Jun 30, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$452K+199% from $151K in Q2 FY2510-Q income statement, on EDGAR
  2. Net income−$2.7MAgainst −$2.3M in Q2 FY2510-Q income statement, on EDGAR
  3. Diluted EPS−$0.75Against −$0.91 in Q2 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$3.6M−17% from $4.3M in Q2 FY2510-Q balance sheet, on EDGAR
  5. Cash from operations−$2.8MAgainst −$2.4M in Q2 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Sintx Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. OSR Health OSRH public float $8M, Dec 31, 2025
  2. NutriBand NTRB
  3. Tenon Medical TNON public float $7M, Jun 30, 2025
  4. SeaStar Medical Holding ICU public float $7M, Jun 30, 2025
  5. ENvue Medical FEED public float $7M, Jun 30, 2025